(Circulation. 1996;94:3069-3073.)
© 1996 American Heart Association, Inc.
Articles |
Codon 102 of the Cardiac Troponin T Gene Is a Putative Hot Spot for Mutations in Familial Hypertrophic Cardiomyopathy
the Unite de Recherches 153 de l'INSERM (J.-F.F., L.C., H.F., G.B., J.B., K.S.), the Service de Biochimie (P.R., B.H.) and the Service de Cardiologie (M.K.), Groupe Hospitalier Pitie-Salpetriere, Paris, France; the Service de Cardiologie, Hopital Ambroise Pare, Boulogne, France (O.D.); the Service de Cardiologie C, Hopital Cardiologique, Lille, France (A.M.); the Service de Cardiologie, Hopital Boucicaut, Paris, France (A.A.H., M.D.); Genethon-CNRS URA 1922, Evry, France (S.F.); and Cardiothoracic Surgery, NHLI Imperial College, London, UK (P.J.T., M.H.Y).
Correspondence to Lucie Carrier, INSERM UR 153, Institut de Myologie, Rue du Mur des Fermiers Generaux, Groupe Hospitalier Pitie-Salpetriere, 47 Boulevard de l'Hopital, 75651 Paris Cedex 13, France. E-mail lcarrier@myologie.infobiogen.fr.
Background Familial hypertrophic cardiomyopathy is a phenotypically and genetically heterogeneous disease. In some families, the disease is linked to the CMH2 locus on chromosome 1q3, in which the cardiac troponin T gene (TNNT2) has been identified as the disease gene. The mutations found in this gene appear to be associated with incomplete penetrance and poor prognosis. Because mutational hot spots offer unique possibilities for analysis of genotype-phenotype correlations, new missense mutations that could define such hot spots in TNNT2 were looked for in unrelated French families with familial hypertrophic cardiomyopathy.
Methods and Results Family members were genotyped with microsatellite markers to detect linkage to the four known disease loci. In family 715, analyses showed linkage to CMH2 only. To accurately position potential mutations on TNNT2, its partial genomic organization was established. Screening for mutations was performed by single-strand conformation polymorphism analysis and sequencing. A new missense mutation, Arg102Leu, was identified in affected members of family 715 because of a G
T transversion located in the 10th exon of the gene. Penetrance of this new mutation is complete; echocardiographic data show a wide range of hypertrophy; and there was no sudden cardiac death in this family.
Conclusions The codon 102 of the TNNT2 gene is a putative mutational hot spot in familial hypertrophic cardiomyopathy and is associated with phenotypic variability. Analysis of more pedigrees carrying mutations in this codon is necessary to better characterize the clinical and prognostic implications of TNNT2 mutations.
Key Words: cardiomyopathy • genetics • heart diseases • hypertrophy
This article has been cited by other articles:
 |
|
 |
|
  P. J. Guinto, T. E. Haim, C. C. Dowell-Martino, N. Sibinga, and J. C. Tardiff Temporal and mutation-specific alterations in Ca2+ homeostasis differentially determine the progression of cTnT-related cardiomyopathies in murine models Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H614 - H626. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. W. Friedrich, P. Bausero, Y. Sun, A. Treszl, E. Kramer, D. Juhr, P. Richard, K. Wegscheider, K. Schwartz, D. Brito, et al. A new polymorphism in human calmodulin III gene promoter is a potential modifier gene for familial hypertrophic cardiomyopathy Eur. Heart J., July 1, 2009; 30(13): 1648 - 1655. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Binder, S. R. Ommen, B. J. Gersh, S. L. Van Driest, A. J. Tajik, R. A. Nishimura, and M. J. Ackerman Echocardiography-Guided Genetic Testing in Hypertrophic Cardiomyopathy: Septal Morphological Features Predict the Presence of Myofilament Mutations Mayo Clin. Proc., April 1, 2006; 81(4): 459 - 467. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. R. Ertz-Berger, H. He, C. Dowell, S. M. Factor, T. E. Haim, S. Nunez, S. D. Schwartz, J. S. Ingwall, and J. C. Tardiff Changes in the chemical and dynamic properties of cardiac troponin T cause discrete cardiomyopathies in transgenic mice PNAS, December 13, 2005; 102(50): 18219 - 18224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Chandra, M. L. Tschirgi, and J. C. Tardiff Increase in tension-dependent ATP consumption induced by cardiac troponin T mutation Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2112 - H2119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Arad, M. Penas-Lado, L. Monserrat, B. J. Maron, M. Sherrid, C. Y. Ho, S. Barr, A. Karim, T. M. Olson, M. Kamisago, et al. Gene Mutations in Apical Hypertrophic Cardiomyopathy Circulation, November 1, 2005; 112(18): 2805 - 2811. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Forissier, P. Charron, S. T. du Montcel, A. Hagege, R. Isnard, L. Carrier, P. Richard, M. Desnos, J. B. Bouhour, K. Schwartz, et al. Diagnostic accuracy of a 2D left ventricle hypertrophy score for familial hypertrophic cardiomyopathy Eur. Heart J., September 2, 2005; 26(18): 1882 - 1886. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Harada and J. D. Potter Familial Hypertrophic Cardiomyopathy Mutations from Different Functional Regions of Troponin T Result in Different Effects on the pH and Ca2+ Sensitivity of Cardiac Muscle Contraction J. Biol. Chem., April 9, 2004; 279(15): 14488 - 14495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Li, G. Z. Czernuszewicz, O. Gonzalez, T. Tapscott, A. Karibe, J.-B. Durand, R. Brugada, R. Hill, J. M. Gregoritch, J. L. Anderson, et al. Novel Cardiac Troponin T Mutation as a Cause of Familial Dilated Cardiomyopathy Circulation, October 30, 2001; 104(18): 2188 - 2193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. M. Hernandez, P. R. Housmans, and J. D. Potter Plasticity in Skeletal, Cardiac, and Smooth Muscle: Invited Review: Pathophysiology of cardiac muscle contraction and relaxation as a result of alterations in thin filament regulation J Appl Physiol, March 1, 2001; 90(3): 1125 - 1136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Y. Ho, H. M. Lever, R. DeSanctis, C. F. Farver, J. G. Seidman, and C. E. Seidman Homozygous Mutation in Cardiac Troponin T : Implications for Hypertrophic Cardiomyopathy Circulation, October 17, 2000; 102(16): 1950 - 1955. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. G D'CRUZ, C. BABOONIAN, H. E PHILLIMORE, R. TAYLOR, P. M ELLIOTT, A. VARNAVA, F. DAVISON, W. J MCKENNA, and N. D CARTER Cytosine methylation confers instability on the cardiac troponin T gene in hypertrophic cardiomyopathy J. Med. Genet., September 1, 2000; 37(9): 18e - 18. [Full Text]
|
|
|
|
 |
|
 N. Frey, W. M. Franz, K. Gloeckner, M. Degenhardt, M. Muller, O. Muller, H. Merz, and H. A. Katus Transgenic rat hearts expressing a human cardiac troponin T deletion reveal diastolic dysfunction and ventricular arrhythmias Cardiovasc Res, August 1, 2000; 47(2): 254 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sorajja, P.M. Elliott, and W.J. Mckenna The molecular genetics of hypertrophic cardiomyopathy: prognostic implications Europace, January 1, 2000; 2(1): 4 - 14. [PDF]
|
|
|
|
 |
|
 V. Ricchiuti and F. S. Apple RNA Expression of Cardiac Troponin T Isoforms in Diseased Human Skeletal Muscle Clin. Chem., December 1, 1999; 45(12): 2129 - 2135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Redwood, J. C. Moolman-Smook, and H. Watkins Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy Cardiovasc Res, October 1, 1999; 44(1): 20 - 36. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Komajda, P. Charron, and F. Tesson Genetic aspects of heart failure Eur J Heart Fail, June 1, 1999; 1(2): 121 - 126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hinkle, A. Goranson, C. A. Butters, and L. S. Tobacman Roles for the Troponin Tail Domain in Thin Filament Assembly and Regulation. A DELETIONAL STUDY OF CARDIAC TROPONIN T J. Biol. Chem., March 12, 1999; 274(11): 7157 - 7164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Priori, J. Barhanin, R. N. W. Hauer, W. Haverkamp, H. J. Jongsma, A. G. Kleber, W. J. McKenna, D. M. Roden, Y. Rudy, K. Schwartz, et al. Genetic and Molecular Basis of Cardiac Arrhythmias: Impact on Clinical Management Parts I and II Circulation, February 2, 1999; 99(4): 518 - 528. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Feetham The Future in Family Nursing Is Genetics and It Is Now Journal of Family Nursing, February 1, 1999; 5(1): 3 - 9. [PDF]
|
|
|
|
|
|
S.G. Priori, J. Barhanin, R.N.W. Hauer, W. Haverkamp, H.J. Jongsma, A.G. Kleber, W.J. McKenna, D.M. Roden, Y. Rudy, K. Schwartz, et al. Genetic and molecular basis of cardiac arrhythmias: Impact on clinical management Eur. Heart J., February 1, 1999; 20(3): 174 - 195. [PDF]
|
|
|
|
|
|
H. L. Sweeney, H. S. Feng, Z. Yang, and H. Watkins Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: Insights into disease pathogenesis and troponin function PNAS, November 24, 1998; 95(24): 14406 - 14410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Maron, J. H. Moller, C. E. Seidman, G. M. Vincent, H. C. Dietz, A. J. Moss, J. A. Towbin, H. M. Sondheimer, R. E. Pyeritz, G. McGee, et al. Impact of Laboratory Molecular Diagnosis on Contemporary Diagnostic Criteria for Genetically Transmitted Cardiovascular Diseases: Hypertrophic Cardiomyopathy, Long-QT Syndrome, and Marfan Syndrome : A Statement for Healthcare Professionals From the Councils on Clinical Cardiology, Cardiovascular Disease in the Young, and Basic Science, American Heart Association Circulation, October 6, 1998; 98(14): 1460 - 1471. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Bonne, L. Carrier, P. Richard, B. Hainque, and K. Schwartz Familial Hypertrophic Cardiomyopathy : From Mutations to Functional Defects Circ. Res., September 21, 1998; 83(6): 580 - 593. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Anan, H. Shono, A. Kisanuki, S. Arima, S. Nakao, and H. Tanaka Patients With Familial Hypertrophic Cardiomyopathy Caused by a Phe110Ile Missense Mutation in the Cardiac Troponin T Gene Have Variable Cardiac Morphologies and a Favorable Prognosis Circulation, August 4, 1998; 98(5): 391 - 397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Charron, O. Dubourg, M. Desnos, M. Bennaceur, L. Carrier, A.-C. Camproux, R. Isnard, A. Hagege, J. M. Langlard, G. Bonne, et al. Clinical Features and Prognostic Implications of Familial Hypertrophic Cardiomyopathy Related to the Cardiac Myosin-Binding Protein C Gene Circulation, June 9, 1998; 97(22): 2230 - 2236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Marian, G. Zhao, Y. Seta, R. Roberts, and Q.-t. Yu Expression of a Mutant (Arg92Gln) Human Cardiac Troponin T, Known to Cause Hypertrophic Cardiomyopathy, Impairs Adult Cardiac Myocyte Contractility Circ. Res., July 19, 1997; 81(1): 76 - 85. [Abstract] [Full Text]
|
|